Drug intelligence / Profile preview

Piperacillin + sulbactam

Development stage
Unknown
Lead developer
Harbin Pharmaceutical
Modality
Small Molecules
Administration
Intravenous, Intramuscular
01

Overview

Piperacillin + sulbactam is a combination antibiotic consisting of piperacillin, a broad-spectrum ureidopenicillin beta-lactam antibiotic, and sulbactam, a beta-lactamase inhibitor. Piperacillin acts by binding to penicillin-binding proteins (PBPs) in bacterial cell walls, inhibiting the final stage of peptidoglycan synthesis and leading to cell lysis. Sulbactam inhibits certain beta-lactamases produced by bacteria that would otherwise degrade piperacillin, thereby extending its antibacterial spectrum to include organisms that produce these enzymes. This combination is primarily used for the treatment of moderate-to-severe infections caused by susceptible Gram-positive and Gram-negative bacteria, including those resistant to other penicillins due to beta-lactamase production.

Other names
piperacillin sulbactam sodium
02

Targets

NeuraminidasePBP (Penicillin-binding protein family)

Beyond the preview

Go deeper on Piperacillin + sulbactam.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Piperacillin + sulbactam.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call